Reduction of Disease Activity and Disability With High-Dose Cyclophosphamide in Patients With Aggressive Multiple Sclerosis

OBJECTIVE: To explore the safety and effectiveness of high-dose cyclophosphamide (HiCy) without bone marrow transplantation in patients with aggressive multiple sclerosis (MS). DESIGN: A 2-year open-label trial of patients with aggressive relapsing-remitting multiple sclerosis (RRMS) given an immuno...

Full description

Saved in:
Bibliographic Details
Main Authors: Krishnan, Chitra, Kaplin, Adam I., Brodsky, Robert A., Drachman, Daniel B., Jones, Richard J., Pham, Dzung L., Richert, Nancy D., Pardo, Carlos A., Yousem, David M., Hammond, Edward, Quigg, Megan, Trecker, Carrilin, McArthur, Justin C., Nath, Avindra, Greenberg, Benjamin M., Calabresi, Peter A., Kerr, Douglas A.
Format: Artigo
Language:Inglês
Published: 2008
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2574697/
https://ncbi.nlm.nih.gov/pubmed/18541787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archneurol.65.8.noc80042
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items